Member Info for Roostersmillions

I'm in on this and have been for a long time.

I have an ISA account on t212 and the current limit is 85000 shares.

My basic Free-trade investment account won't let my buy any more. You have to upgrade.

This is limiting thousands of retail customers from investing here.

I'm not too sure the patent will make much difference until the drug has, at least, some results from human trials.

The imminent big news will be the dog trial and tie up with a pet or vet company. Then we get revenue, which will be a game changer. With revenue market cap is got to be 30 million plus??? So 10x

Pedro's quote didn't age well......

I'm baffled by the plunge

Looks like a rise today

I think he'll struggle to make 5%.

All his best efforts and it's gone down.

MillonAir.

'So not sure if it's this genf or the USA part'.

What is this you typed. What US part? No company has bid for GENF. Don't blame AI for your inaccuracies.

I could say Nvidia have bid for GENF and be as accurate as you.

Where is the link to them wanting to buy GENF.

Stop spamming the board.

Until a couple of days ago, this was an informative community, with knowledgeable posters that have been invested in GENF for ages. Then you arrived and dragged the SP down to a new low

So Serepta haven't tried to buy GENF.

But you clearly state they have. That is misleading.

MillonAir

You said 'This company in the past tried buying GENF for other product.'

Which company are you specifically talking about and do you have a link to the bid?

I think some of your posts are quite misleading.

Pump and dump ever.

The dog trial is massive for me. Success (which is likely) will add real value to the company in terms of partnership with a pet care co or vet and a short run in to an income stream.

Today will be the biggest business day by volume for sometime, all buys, and not a glimmer of a SP rise.

Very odd.

Good numbers on today's 1/2 year.

All very positive for the future I think.

You'd hope that the wall street journal had a reliable source and done a bit of legwork before publishing.

Shell want the SP low

Answering my own question.

The average premium offered this year is 37% per AJ Bell.

It was higher the last two years.

It's been more

Could have waited until I'd reinvested the divs on Friday..........

But beggars can't be choosers. Any one have any idea what the average supplement on market cap is for takeovers. Might give us a clue.

New development on the eye treatment, but the rest was stuff that we already knew.

The SP is frustrating, but I'm convinced it will come good, it's just a slow process with medical shares.

Worst case scenario depends on who else is dragged in.

Another late buy slipped through this morning nearly 1.2 million.

Something afoot?

Broker upgrade